Trial Profile
Phase Ib trial of EPI 589 in healthy subjects
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 10 Jan 2019
Price :
$35
*
At a glance
- Drugs R-troloxamide-quinone (Primary)
- Indications Neurodegenerative disorders
- Focus Adverse reactions
- 11 Feb 2014 New trial record
- 31 Jan 2014 EPI-589 is currently in phase 1B, according to an Edison Pharmaceuticals media release.